The BH3 mimetic ABT-737 increases treatment efficiency of paclitaxel against hepatoblastoma

BACKGROUND: The primary goal of current chemotherapy in hepatoblastoma (HB) is reduction of tumour volume and vitality to enable complete surgical resection and reduce risk of recurrence or metastatic disease. Drug resistance remains a major challenge for HB treatment. In some malignancies inhibitio...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lieber, Justus, Eicher, Carmen, Wenz, Julia, Kirchner, Bettina, Warmann, Steven W, Fuchs, Jörg, Armeanu-Ebinger, Sorin
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2011
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3176244/
https://ncbi.nlm.nih.gov/pubmed/21854558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-362
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky